Full-Time

Global Product Development Lead

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

201-500 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Senior, Expert

Remote in USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • Master’s or PhD strongly preferred; bachelor’s degree with minimum 10+ years considered in lieu of advanced degree.
  • 10+ years leading cross-functional product teams within the pharma/biotech domain required
  • Prior experience in oncology development and/or radiopharmaceuticals will be a distinct advantage.
  • Experience in clinical Phase 2 through approval required, specifically in the musculoskeletal therapeutic area strongly preferred.
  • Demonstrated ability to think strategically, communicate effectively, and collaborate in a matrixed team environment.
Responsibilities
  • Leads technical cross-functional team to achieve milestones and advance through stage-gates.
  • Champion the development of late-stage radiopharmaceutical compounds, ensuring alignment with company strategy and objectives.
  • Contribute to clinical trial strategy, gathering input from stakeholders and providing expertise.
  • Create integrated development plan encompassing timelines for all functions.
  • Overcome obstacles to ensure programs progress in a timely manner.
  • Showcase prowess in strategic thinking, particularly in the realm of cross-functional drug development, guiding matrixed teams through complex decision-making and risk management processes.
  • Co-lead and create strategic direction with Global Commercial Lead.
  • Foster a collaborative spirit, working seamlessly with teams spanning clinical, non-clinical, regulatory affairs, quality, manufacturing and supply chain, commercial, medical affairs and program management to formulate plans that achieve program milestones and objectives.
  • Partner with Clinical and Regulatory Affairs to craft the ideal development pathway for approval, aiming to meet product attributes and commercial objectives.
  • Assume accountability for reporting the progression of assigned drug development program, presenting data through dashboards and management reviews.
  • Create and execute comprehensive product development plans and data packages, paving the way for informed go/no-go decisions and continuous progression towards product approval.
  • Engage subject matter experts and thought leaders, both within and outside the organization, fostering rich scientific dialogue, extracting insights, and refining development plans and strategies.
  • Excellent team management skills required.
  • Lead team and manage conflicting views diverging views on team, and spearhead team towards solutions and progress.
  • Liaise with senior management for input and updating programs.
  • Excellent presentation skills and executive presence required.
  • Lead development, regulatory, CMC, clinical operations, manufacturing through preparations for submitting regulatory filings and ultimately product launch.
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells products for diagnosing and treating cancer and rare diseases using targeted radiation. Their products aim to enhance treatment decisions and offer personalized therapy for conditions that lack effective solutions. The company focuses on areas such as prostate and kidney cancers, glioma, sarcoma, and bone marrow conditioning. Telix has a global supply chain to manufacture and distribute its specialized products to healthcare providers and patients. Unlike many competitors, Telix emphasizes sustainability, patient care, and ethical practices in its operations. The goal of Telix Pharmaceuticals is to improve the quality of life for patients by providing advanced diagnostic and therapeutic options.

Company Stage

IPO

Total Funding

$14.8M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

18%

1 year growth

43%

2 year growth

106%
Simplify Jobs

Simplify's Take

What believers are saying

  • Telix's completion of the BLA submission for TLX250-CDx positions it for potential market leadership in kidney cancer imaging.
  • Positive data from the ProstACT SELECT trial for TLX591 indicates promising efficacy in prostate cancer treatment, enhancing the company's therapeutic portfolio.
  • The FDA Fast Track designation for TLX101-CDx for glioma imaging accelerates its path to market, potentially improving outcomes for brain cancer patients.

What critics are saying

  • The recent withdrawal of its IPO due to unfavorable market conditions may impact Telix's financial flexibility and investor confidence.
  • The competitive landscape in biopharmaceuticals, especially in oncology, requires continuous innovation to maintain market position.

What makes Telix Pharmaceuticals unique

  • Telix Pharmaceuticals specializes in targeted radiation therapies, setting it apart from traditional biopharmaceutical companies that may not focus on this innovative approach.
  • The company's robust global supply chain ensures the availability and delivery of its products worldwide, providing a competitive edge in distribution and accessibility.
  • Telix's commitment to sustainability and ethical practices integrates patient care and environmental responsibility into its operations, distinguishing it from competitors.

Help us improve and share your feedback! Did you find this helpful?